Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski(European Molecular Biology Laboratory), Gerard Drewes(Unknown), Dirk Eberhard(Karolinska Institutet), Thilo Werner(GlaxoSmithKline (Germany)), Maria Fälth Savitski(GlaxoSmithKline (Germany)), Rebecca Dovega(German Cancer Research Center), Bernhard Küster(German Cancer Research Center), P. Nordlund(Karolinska Institutet), Marcus Bantscheff(Roche (Switzerland)), Rozbeh Jafari(Science for Life Laboratory), Friedrich Reinhard(GlaxoSmithKline (Germany)), Daniel Martinez Molina(Karolinska Institutet), Holger Franken(GlaxoSmithKline (Germany)), Susan Klaeger(Broad Institute)
Cited by 1,220
Related Papers
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Quantitative mass spectrometry in proteomics: a critical review
|Analytical and Bioanalytical Chemistry|2007|1.7k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
|Analytical and Bioanalytical Chemistry|2012|801
A deep proteome and transcriptome abundance atlas of 29 healthy human tissues
|Molecular Systems Biology|2019|790